News and Insights of 3D Printing and Manufacturing
Chinese drug 3D printing firm Triastek has announced a partnership with global pharmaceuticals company Eli Lilly to research and develop 3D printed oral drugs for the gastrointestinal tract.
US biotechnology start-up Precise Bio has gained the backing of Carl Zeiss Meditec to fund the further development of its 3D printed cornea transplants.
When the Department of Automatic Control and Systems Engineering (ACSE) at The University of Sheffield was looking for a way to accurately 3D print bioelectronic sensors, it reached out to Intertronics for support. The company supplied mixing and dispensing equipment to improve the consistency and quality of the mix – achieve better printing definition and reduced blockages in the nozzle of the 3D printer.
Prellis Biologics Inc., a biotherapeutics company with human tissue engineering capabilities, has entered into a collaboration and license option agreement with Sanofi S.A., an innovative global healthcare company. The collaboration will focus on the discovery of antibodies with Prellis’ first-in-class external human immune system (EXIS), and leverages Prellis’ ability to engineer fully-human lymph node organoids (LNOs) and recreate immune responses in vitro to deliver antibodies with significant genetic diversity.
Biomedical technology company, ActivArmor, through its partnership with US-based 3D printer manufacturer, Fusion3, is expanding its distribution model to bring the company’s hygienic, waterproof, plastic custom cast fabrication directly into hospitals and clinics across the country.
Researchers at Japan’s Tohoku University Graduate School of Dentistry have found Digital Light Processing (DLP) 3D printing to be a more effective means of producing dental crowns than conventional milling.
Biogenic Dental Corporation is a family-owned dental laboratory operating since 1906. Located in the heart of Central New York, it is a full-service lab that provides high-quality dental restorations to their customers.
Carl Zeiss Meditec, one of the world’s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.
Triastek, Inc., a company specializing in 3D printing of pharmaceuticals, entered into a collaboration with Eli Lilly and Company, a leading global pharmaceutical company, to leverage the advantages of MED 3D printing technology to enable precisely targeted and programmed release of drugs in specific regions of the GI tract.
A research team led by Boston University has used 3D printing technology to develop a miniature replica of a human heart – and it beats like the real thing.